News
1 minute read

MBHB Partner Kevin Noonan Authors Nature Biotechnology Article Entitled, "Why axing TPP was a lost opportunity for biotech"

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan authored an article entitled, “Why axing TPP was a lost opportunity for biotech” that appears in the March 7, 2017 online edition of Nature Biotechnology. President Donald Trump, as one part of his campaign stump speech and a large part of his appeal to his supporters, made much of his disdain for international trade agreements and their effects on the job market in the United States. View the article